NMN: a precursor of NAD+ under investigation

Research into the biology of ageing has produced a number of molecules that have attracted broad attention in recent years. One of them is NMN (nicotinamide mononucleotide). What exactly is NMN, and why does it play a role in ageing research?

NMN is a precursor of NAD+ (nicotinamide adenine dinucleotide), a molecule that occurs in every cell of the body and takes part in many essential functions. NAD+ is best known for its role in energy metabolism and in the enzymatic repair of DNA.

The significance of NAD+

NAD+ is a coenzyme that is required for numerous biological processes. It plays a central role in energy production in the mitochondria, the so-called power plants of the cell. DNA repair, the regulation of the circadian rhythm and gene expression also depend to a large extent on NAD+.

Measurements in animals and in human tissue samples indicate that NAD+ concentrations decline with increasing age. In the scientific literature, this decline has been discussed in connection with a range of age-related changes, such as lower energy metabolism, changes in cognitive performance and a higher susceptibility to disease. Whether the decline is a cause or a consequence of these changes is still a matter of research.

NMN as an NAD+ precursor

Because NMN is converted directly into NAD+ by the enzyme family NMNAT, researchers have asked whether supplying NMN can raise NAD+ levels in tissues. This question is the reason NMN became a candidate molecule in ageing research and in studies of age-related conditions.

Research findings on NMN

A large number of studies, most of them in animals, have examined NMN. The following results are reported in the literature; they refer to the respective model and cannot be transferred directly to humans:

  • Metabolic function: in mouse studies, NMN administration was associated with changes in insulin sensitivity and glucose metabolism. The authors discussed this as a possible starting point for research into diabetes and metabolic disorders.
  • Endurance: older mice that received NMN showed higher physical performance in treadmill tests than untreated animals, which the researchers interpreted as a lead for studies on muscle ageing.
  • Cardiovascular parameters: animal experiments reported changes in heart function and in the elasticity of blood vessels after NMN administration.
  • Nervous system: in animal models, NMN has been examined with regard to age-related changes in the brain and to cognitive test results; the data come from mice and are preliminary.
  • DNA repair: because NAD+ is a substrate of DNA repair enzymes, researchers have investigated whether NMN influences the repair capacity of cells in culture and in animals. Whether this has any relevance for cancer or other age-related diseases in humans is unknown.

Proposed mechanisms

The effects reported in the animal literature are mostly attributed to the increase in NAD+ levels. On the cellular level, researchers discuss the following mechanisms:

  • Sirtuins: this protein family is involved in the regulation of ageing processes in model organisms. Sirtuins require NAD+ as a cofactor. The hypothesis is that an increase in NAD+ raises sirtuin activity; this has been shown in cell and animal models, and its relevance in humans is under investigation.
  • Mitochondrial function: since NAD+ is required for energy production in the mitochondria, mitochondrial efficiency is one of the parameters that studies on NMN measure.
  • DNA repair enzymes: enzymes such as PARP consume NAD+ when they repair DNA damage. NAD+ availability is therefore a research variable in this context.
  • Circadian rhythm: NAD+ interacts with the molecular clock of the cell. In mouse models, researchers have examined whether NMN influences sleep-wake patterns and metabolic rhythms.

Clinical studies and future research

Although the results from animal models are the basis for the current interest, most research on NMN is still at an early stage, especially where humans are concerned. A few small human studies exist:

  • One investigation examined the oral intake of NMN in healthy men and reported that it was tolerated in the study period and that NAD+ metabolites in the blood rose.
  • Another small trial examined insulin sensitivity in overweight, postmenopausal women during NMN intake and reported changes in muscle insulin signalling; the study was short and had few participants.

Future research is likely to concentrate on the following topics:

  • Long-term studies on safety and on the effects of NMN in humans
  • Dose and route of administration
  • Possible applications in specific age-related conditions
  • Combinations with other compounds studied in ageing research

Challenges and open questions

  • Bioavailability: how well NMN is absorbed after oral intake, and whether it is first converted to nicotinamide riboside or nicotinamide in the gut, is a central question. Researchers are examining transport mechanisms and formulations.
  • Long-term effects: the long-term consequences of NMN intake in humans are not yet known.
  • Individual differences: results may vary between individuals depending on age, health status and genetic factors.
  • Regulatory status: in some countries NMN is sold as a food supplement, in others it is regarded as a substance for research. In the European Union, NMN counts as a novel food without authorisation and may not be marketed for human consumption.

Summary and outlook

NMN is one of the most intensively studied molecules in ageing research. As a precursor of NAD+, it is used in cell and animal models to test the hypothesis that NAD+ availability influences cellular ageing. The results from animal studies are the reason for the broad interest, but they are results from animals.

Research on NMN in humans is still at an early stage, and the coming years of clinical studies will show which of the observations from animal models hold up. Independently of this research, a balanced diet, physical activity and sufficient sleep remain the basis of healthy ageing according to current scientific understanding.